Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    Open Studies | "Chagas Disease"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Chagas Disease" (8 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Prospective Study of a Pediatric Nifurtimox Formulation for Chagas' Disease
Condition: Chagas Disease
Interventions: Drug: Nifurtimox (BAYA2502);   Drug: Nifurtimox (BAYA2502) followed by Placebo
2 Recruiting Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)
Condition: Chagas Disease With Heart Failure
Intervention: Drug: Aspirin
3 Recruiting Selenium Treatment and Chagasic Cardiopathy (STCC)
Condition: Chagas Disease
Interventions: Drug: Selenium;   Drug: Placebo (for Selenium)
4 Recruiting CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)
Condition: Chagas Disease
Interventions: Drug: Nifurtimox;   Drug: Benznidazole;   Drug: Placebo
5 Recruiting Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease
Conditions: Chagas Disease;   Trypanosomiasis, South American;   South American Trypanosomiasis;   Disease, Chagas
Interventions: Drug: Fexinidazole;   Drug: Placebo
6 Recruiting Impact of the Pharmaceutical Care on the Quality of Life in Patients With Chagas Heart Disease
Condition: Chagas Heart Disease
Interventions: Other: Standard care and Pharmaceutical care;   Other: Standard care
7 Recruiting Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Condition: Parasitic Disease
Intervention:
8 Not yet recruiting Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
Conditions: Chagas Cardiomyopathy;   Non-sustained Ventricular Tachycardia;   At Least 10 Points in Rassi Risk Score for Death
Interventions: Procedure: ICD implantation;   Drug: amiodarone hydrochloride

Study has passed its completion date and status has not been verified in more than two years.